Zonisamide for weight loss in obese adults: a randomized controlled trial.
about
Pharmacotherapies for obesity: past, current, and future therapiesLong-term drug treatment for obesity: a systematic and clinical reviewMissing data in randomized clinical trials for weight loss: scope of the problem, state of the field, and performance of statistical methodsObesity pharmacotherapy: current perspectives and future directionsObesity: Current and potential pharmacotherapeutics and targets.The pharmacological treatment and management of obesity.Tackling obesity: new therapeutic agents for assisted weight loss.Zonisamide Combined with Cognitive Behavioral Therapy in Binge Eating Disorder: A One-year Follow-up Study.Combinations of drugs in the Treatment of Obesity.Cellular bioenergetics as a target for obesity therapy.Sample size in obesity trials: patient perspective versus current practice.Weight changes in obese adults 6-months after discontinuation of double-blind zonisamide or placebo treatment.Pharmacological management of binge eating disorder: current and emerging treatment options.Sentra PM (a Medical Food) and Trazodone in the Management of Sleep Disorders.Current and investigational antiobesity agents and obesity therapeutic treatment targets.Behavioral and pharmacologic therapies for obesity.Present and future: pharmacologic treatment of obesityZonisamide for bipolar disorder, mania or mixed states: a randomized, double blind, placebo-controlled adjunctive trial.Imaging of brain dopamine pathways: implications for understanding obesity.Current and future drug targets in weight managementTreatment options for obesity and potential therapies on the horizonPlacebo-controlled trial of zonisamide for the treatment of alcohol dependence.Clear indications of emotion depend on vivid stimuli.New anticonvulsant medication uses in bipolar disorder.New medication treatment options for bipolar disorders.Zonisamide: newer antiepileptic agent with multiple mechanisms of action.Safety and tolerability of emerging pharmacological treatments for bipolar disorder.Rate of weight loss can be predicted by patient characteristics and intervention strategiesDrug Insight: appetite suppressants.Emerging drugs for eating disorder treatment.Investigational therapies in the treatment of obesity.Comorbidity of eating disorders with bipolar disorder and treatment implications.Zonisamide for bipolar depression.Side effects of antiepileptics--a review.Bupropion for weight reduction.Pharmacotherapeutic options for overweight adolescents.Orlistat for the management of overweight individuals and obesity: a review of potential for the 60-mg, over-the-counter dosage.Zonisamide for the treatment of Parkinson's disease.Zonisamide for weight reduction in obese adults: a 1-year randomized controlled trial.Long-term safety and effectiveness of zonisamide in the treatment of epilepsy: a review of the literature.
P2860
Q21296814-31F4A3B9-814B-4182-943D-B72762FE2472Q22253010-5E6D286B-2139-4676-91A4-98DDEA96D3D2Q24550382-72078CD6-5A79-4594-A9F0-0FBB1B0FD701Q26828559-A5B9A1F2-0E67-4EB1-B6B9-F1659BE044CFQ30243992-6DC12534-0DDC-4172-A15A-580E871BDA77Q30399340-2B4B7CC2-C27C-4137-AF95-8F44E8C6269CQ30401145-5795990A-3DEA-4B68-8EBE-C828576A9338Q33570632-46F6C9E5-2FC1-42BA-9C75-6D38625967DDQ33664063-0C3A250C-97EC-4E5A-97D8-3156DD3FE08FQ33894407-F77E27AE-5CC3-4E3F-8C8E-C4F7A7A22143Q34039120-3F024250-B898-4353-A451-F486E122249AQ34056313-FEB875A0-6801-49B4-9559-E80E17C943D3Q34278450-CECE9B06-321B-4DF4-BCF2-DBE42C057729Q34343318-83F2F597-5AF4-4A7C-843C-39190178CD11Q34344786-51742682-8E1F-4663-9082-E881AD0612D7Q34543656-EE4B4FDE-3633-4DB3-AD5D-6B1840C1B7AEQ34572487-7F0E8ACF-9883-41CF-AEA1-34EA94500040Q34637512-EFC9C567-4DF9-48F3-90D8-D471E58C6B1AQ34995403-35F4994D-16F6-4DE9-989D-5EE58B728A2CQ35089784-4F9A6B31-19C6-4B65-A4C8-8A8311F1422FQ35111291-0211473C-7CDE-4B33-B37E-11BF8D96F085Q35167660-DF64E260-09D5-4085-8B60-1E9CEE560EF3Q35478174-3E21B93D-DA40-4CC8-B33C-FF33295AA716Q35673095-025A9A86-7A94-4032-91DE-CD6B52F59BD9Q35872066-41EEE792-4FD8-4F2F-9A57-60307A345272Q36106890-438E2B0B-CB95-4237-ADAE-CBB2DF363BF1Q36199036-527D7F97-3BC6-40DA-9C7F-EFAE04985B0BQ36248712-F49270FA-9FEE-4A97-B704-521E973C8186Q36304086-928A78FC-2EF9-427D-BB6A-04A508720B11Q36458423-B2A4350A-84DF-4316-8F0E-1AD028324417Q36543067-38203C9A-1AA9-47AA-87F3-55BD15CF1D48Q36677648-1EB90096-66A7-4D57-99BE-4D3DA6F437E6Q36681343-F84C1851-60A7-4016-9E3D-629EFA90C35CQ36686139-F494B82E-A06E-449C-9784-76AB7CCB8686Q36691753-72893C3E-209C-443F-9386-9B91B3095050Q36891391-6F933001-84E2-4E36-9195-B8C267145D79Q36904913-7A19BD6B-4C9D-48CB-8364-80160BBEACE0Q36941885-6815DF0A-F6A3-4F49-A942-30C06700272AQ37120893-E3F00A01-4337-4CCA-9414-05914F0B826EQ37224576-DB88401E-D76C-4E9E-87FF-409EBA8069B5
P2860
Zonisamide for weight loss in obese adults: a randomized controlled trial.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Zonisamide for weight loss in obese adults: a randomized controlled trial.
@ast
Zonisamide for weight loss in obese adults: a randomized controlled trial.
@en
Zonisamide for weight loss in obese adults: a randomized controlled trial.
@nl
type
label
Zonisamide for weight loss in obese adults: a randomized controlled trial.
@ast
Zonisamide for weight loss in obese adults: a randomized controlled trial.
@en
Zonisamide for weight loss in obese adults: a randomized controlled trial.
@nl
prefLabel
Zonisamide for weight loss in obese adults: a randomized controlled trial.
@ast
Zonisamide for weight loss in obese adults: a randomized controlled trial.
@en
Zonisamide for weight loss in obese adults: a randomized controlled trial.
@nl
P2093
P356
P1476
Zonisamide for weight loss in obese adults: a randomized controlled trial.
@en
P2093
Deborah M Franciscy
H Ryan Wagner
K Ranga R Krishnan
Kishore M Gadde
P304
P356
10.1001/JAMA.289.14.1820
P407
P577
2003-04-01T00:00:00Z